Legal & General Group Plc - APREA THERAPEUTICS INC ownership

APREA THERAPEUTICS INC's ticker is APRE and the CUSIP is 03836J102. A total of 2 filers reported holding APREA THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Legal & General Group Plc ownership history of APREA THERAPEUTICS INC
ValueSharesWeighting
Q1 2021$6,0000.0%1,2730.0%0.00%
Q4 2020$6,000
-81.2%
1,273
-2.6%
0.00%
Q3 2020$32,000
-49.2%
1,307
-18.9%
0.00%
Q2 2020$63,000
+75.0%
1,612
+54.1%
0.00%
Q1 2020$36,000
-39.0%
1,046
-18.3%
0.00%
Q4 2019$59,0001,2810.00%
Other shareholders
APREA THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
5AM Venture Management, LLC 1,377,654$6,778,0002.28%
Versant Venture Management, LLC 1,426,328$7,018,0000.73%
COASTAL INVESTMENT MANAGEMENT, L.P. 41,965$206,0000.38%
Redmile Group, LLC 1,268,718$6,242,0000.08%
Gyon Technologies Capital Management, LP 41,801$206,0000.07%
SECTORAL ASSET MANAGEMENT INC 163,681$805,0000.06%
Palo Alto Investors LP 128,770$634,0000.03%
Walleye Capital LLC 100,800$496,0000.03%
Virtus ETF Advisers LLC 10,261$50,0000.02%
Candriam S.C.A. 362,346$1,783,0000.01%
View complete list of APREA THERAPEUTICS INC shareholders